- Home
- BYSI vs APYX Comparison
BYSI vs APYX Comparison
Compare BYSI & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYSI
- APYX
- Stock Information
- Founded
- BYSI 2010
- APYX 1982
- Country
- BYSI United States
- APYX United States
- Employees
- BYSI N/A
- APYX N/A
- Industry
- BYSI Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- BYSI Health Care
- APYX Health Care
- Exchange
- BYSI Nasdaq
- APYX Nasdaq
- Market Cap
- BYSI 71.0M
- APYX 84.7M
- IPO Year
- BYSI 2017
- APYX 1987
- Fundamental
- Price
- BYSI $2.18
- APYX $2.26
- Analyst Decision
- BYSI
- APYX Hold
- Analyst Count
- BYSI 0
- APYX 2
- Target Price
- BYSI N/A
- APYX N/A
- AVG Volume (30 Days)
- BYSI 92.5K
- APYX 104.7K
- Earning Date
- BYSI 08-11-2025
- APYX 08-07-2025
- Dividend Yield
- BYSI N/A
- APYX N/A
- EPS Growth
- BYSI N/A
- APYX N/A
- EPS
- BYSI N/A
- APYX N/A
- Revenue
- BYSI N/A
- APYX $47,288,000.00
- Revenue This Year
- BYSI N/A
- APYX $2.25
- Revenue Next Year
- BYSI N/A
- APYX $6.76
- P/E Ratio
- BYSI N/A
- APYX N/A
- Revenue Growth
- BYSI N/A
- APYX N/A
- 52 Week Low
- BYSI $0.98
- APYX $0.76
- 52 Week High
- BYSI $3.44
- APYX $2.73
- Technical
- Relative Strength Index (RSI)
- BYSI 44.93
- APYX 56.94
- Support Level
- BYSI $2.15
- APYX $1.85
- Resistance Level
- BYSI $2.35
- APYX $2.73
- Average True Range (ATR)
- BYSI 0.13
- APYX 0.25
- MACD
- BYSI -0.05
- APYX -0.03
- Stochastic Oscillator
- BYSI 8.57
- APYX 54.37
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.